Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
ClinicalTrials.gov Identifier: NCT01897532.
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 1,029
- Institution
- Boehringer Ingelheim (Netherlands)
External Links
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.